This brand name is authorized in Ecuador, Mexico, Tunisia, South Africa
The drug APROVASC contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Irbesartan
UNII J0E2756Z7N - IRBESARTAN
|
|
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II. The selective antagonism of the angiotensin-II (AT1) receptors results in increases in plasma renin levels and angiotensin-II levels, and a decrease in plasma aldosterone concentration. |
|
2
Amlodipine
UNII 864V2Q084H - AMLODIPINE BESYLATE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| APROVASC Film-coated tablet | Marketing Authorisation Holder | MPI, Generic |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C09DB05 | Irbesartan and amlodipine | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 363091112, 363161112, 363301112 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 180M2011 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9263261, 9263262, 9263263 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 46/7.1.3/0542, 46/7.1.3/0543, 46/7.1.3/0544, 46/7.1.3/0545 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
